


Oqory Revenue
Biotechnology Research • San Diego, California, United States • 1-10 Employees
Oqory revenue & valuation
| Annual revenue | $85,555 |
| Revenue per employee | $86,000 |
| Estimated valuation?This valuation is estimated based on industry average for the Biotechnology Research industry and current estimated revenues | $273,776 |
| Total funding | No funding |
Key Contact at Oqory
Michael G King
Chief Executive Officer
Company overview
| Headquarters | San Diego, California, United States |
| NAICS | 541714 |
| Keywords | Biotechnology, Clinical Trials, Oncology, Cancer Research, Antibody-Drug Conjugates (Adcs) |
| Employees | 1-10 |
About Oqory
Oqory is a clinical-stage biotechnology company specializing in developing advanced antibody-drug conjugates (ADCs) to treat multiple oncology indications. Our proprietary ADC discovery platform empowers us to deliver innovative therapies with enhanced efficacy, safety, and tolerability. With a robust pipeline of clinical and preclinical candidates, including our lead asset OQY-3258, a best-in-class ADC targeting TROP2, we aim to transform cancer treatment outcomes for patients globally. Founded in 2012, Oqory has established itself as a leader in ADC innovation, driving clinical progress and redefining possibilities in oncology. Key Highlights: Phase 3-ready lead asset OQY-3258 with robust clinical data and trials underway in China. Advanced-stage pipeline addressing multiple oncology indications. Integrated ADC discovery platform enabling end-to-end development of innovative therapies. Join us in transforming the future of cancer care.
Employees by Management Level
Total employees: 1-10
Seniority
Employees
Employees by Department
Oqory has 1 employees across 1 departments.
Departments
Number of employees
Funding Data
Oqory has never raised funding before.
Frequently asked questions
4.8
40,000 users



